Merck Operating Income 2010-2024 | MRK

Merck operating income for the twelve months ending September 30, 2024 was $14.160B, a 73.68% increase year-over-year.

  • Merck annual operating income for 2023 was $2.954B, a 83.84% decline from 2022.
  • Merck annual operating income for 2022 was $18.282B, a 38.51% increase from 2021.
  • Merck annual operating income for 2021 was $13.199B, a 137.91% increase from 2020.

Merck Operating Income 2010-2024 | MRK

  • Merck annual operating income for 2023 was $2.954B, a 83.84% decline from 2022.
  • Merck annual operating income for 2022 was $18.282B, a 38.51% increase from 2021.
  • Merck annual operating income for 2021 was $13.199B, a 137.91% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$710.1B
Novo Nordisk (NVO)$471.5B
Johnson & Johnson (JNJ)$373.6B
AbbVie (ABBV)$312.7B
Novartis AG (NVS)$213.1B
AstraZeneca (AZN)$203.5B
Pfizer (PFE)$145.4B
Sanofi (SNY)$122.5B
Innoviva (INVA)$1.2B